CN104082751A - 一种含有虾青素的深海鱼油软胶囊 - Google Patents
一种含有虾青素的深海鱼油软胶囊 Download PDFInfo
- Publication number
- CN104082751A CN104082751A CN201410297613.6A CN201410297613A CN104082751A CN 104082751 A CN104082751 A CN 104082751A CN 201410297613 A CN201410297613 A CN 201410297613A CN 104082751 A CN104082751 A CN 104082751A
- Authority
- CN
- China
- Prior art keywords
- fish oil
- astaxanthin
- soft capsule
- deep sea
- sea fish
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 21
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 21
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 21
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 21
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 21
- 235000021323 fish oil Nutrition 0.000 title claims abstract description 20
- 239000007901 soft capsule Substances 0.000 title claims abstract description 13
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000019198 oils Nutrition 0.000 claims abstract description 3
- 239000002775 capsule Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 3
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 3
- 241000251468 Actinopterygii Species 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明提供了一种含有虾青素的深海鱼油软胶囊,主要有效成分是:深海鱼油[含有EPA(二十碳五烯酸)、DHA(二十二碳六烯酸)]、虾青素油(含有虾青素)。主要辅料为水、维生素E、甘油和食用动物明胶。本发明的有益效果是:该鱼油软胶囊将ω-3高度不饱和脂肪酸(EPA、DHA)和具有强抗氧化作用的虾青素有效结合在一起,成分之间进一步协同作用,能够有效预防心脑血管疾病,并且可以提高免疫力,清除体内自由基,起到延缓衰老的作用。
Description
(一)技术领域
本发明涉及一种鱼油软胶囊,尤其是一种含有虾青素的深海鱼油软胶囊,属于保健食品技术领域。
(二)背景技术
目前,随着生活水平的不断提高,人们对高脂肪肉类食品的摄入量不断增加,伴随而来的是血液中脂肪含量的不断升高,并且由此引起的动脉血管硬化、血栓、冠心病等疾病,日益影响和危害了中老年人的健康和生活质量。为了预防此类疾病的发生,人们开始食用一些鱼油类产品,由于市场上现有的各种鱼油类产品普遍存在:有效成分简单、功效成分含量低、功效成分配比不合理,造成产品功能单一、效果不明显的缺点,很难起到理想的预防疾病的作用。
(三)发明内容
本发明为了弥补现有技术的不足,提供了一种含有虾青素的深海鱼油软胶囊,主要有效成分是:深海鱼油[含有EPA(二十碳五烯酸)、DHA(二十二碳六烯酸)]、虾青素,主要辅料为水、维生素E、甘油和食用动物明胶。
深海鱼油中的EPA、DHA成分是一种特殊的不饱和脂肪酸,是有益于血液循环的保护因子。EPA可协助清除附着于血管壁上的胆固醇与硬化斑,降低血液中胆固醇水平,有助于保持血液畅通流动,抑制不正常血液凝集、预防血栓产生,阻止中风或心肌梗塞的发生。
虾青素在体内具有显著升高HDL和降LDL的功效,可用来预防动脉硬化、冠心病和缺血性脑损伤。虾青素有很强的诱导细胞***的活性,具有重要的免疫调节作用。虾青素很容易通过血脑屏障和细胞膜,能有效地防止视网膜的氧化和感光胞的损伤,以及对中枢神经***尤其是对大脑起到保护作用,尤其是针对老年性视网膜黄斑变性的效果要比叶黄素更加显著。虾青素的强抗氧化性可能使它成为潜在的光保护剂,有效清除引起皮肤老化的自由基,阻止皮肤光老化。
维生素E能够保护高度不饱和脂肪酸(EPA、DHA)不被氧化,延长产品保质期。 本发明的有益效果是,该鱼油软胶囊将ω-3高度不饱和脂肪酸(EPA、DHA)和虾青素有效结合在一起,成分之间进一步协同作用,能够有效预防心脑血管疾病。并且可以提高免疫力,清除体内自由基,起到延缓衰老的作用。
(四)具体实施方式
1、配制内容物:将原材料深海鱼油、虾青素油、维生素E按照一定的配方混合到一起,搅拌均匀,内容物功效成分净含量的质量百分比为:EPA:30~35%、DHA:15~20% 、虾青素:1~3%。。
2、制作胶囊体材料:以食用明胶、甘油和纯净水为囊体原料,将甘油和纯净水按照比例注入溶胶罐内,加热搅拌至75℃左右,再加入明胶,继续搅拌20~30分钟后真空脱泡,制作得到囊体材料。
3、将配好的内容物和胶囊体经过压丸、成型、洗丸、干燥,制成成品深海鱼油软胶囊。
Claims (2)
1.一种含有虾青素的深海鱼油软胶囊,其特征在于:胶囊内容物原料的质量百分比为:鱼油[含有EPA(二十碳五烯酸)、DHA(二十二碳六烯酸)]:80~90% 、虾青素油(含有虾青素):10~20% 、维生素E:1% 。
2.根据权利要求1所述的一种含有虾青素的深海鱼油软胶囊,其特征在于:胶囊内容物功效成分的质量百分比为EPA:30~35%、DHA:15~20% 、虾青素:1~3%,其余成分为1%的维生素E和鱼油中的其它非功效成分。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410297613.6A CN104082751A (zh) | 2014-06-29 | 2014-06-29 | 一种含有虾青素的深海鱼油软胶囊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410297613.6A CN104082751A (zh) | 2014-06-29 | 2014-06-29 | 一种含有虾青素的深海鱼油软胶囊 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104082751A true CN104082751A (zh) | 2014-10-08 |
Family
ID=51630599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410297613.6A Pending CN104082751A (zh) | 2014-06-29 | 2014-06-29 | 一种含有虾青素的深海鱼油软胶囊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104082751A (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106942727A (zh) * | 2017-04-20 | 2017-07-14 | 北京市永康年健康科技有限责任公司 | 一种用于降低血脂的dha藻油制品及其制备方法和应用 |
CN107080769A (zh) * | 2017-05-17 | 2017-08-22 | 王茹 | 一种治疗各种慢性疾病的天然药物及医用配方食品 |
CN107772190A (zh) * | 2017-10-19 | 2018-03-09 | 杭州鑫伟低碳技术研发有限公司 | 一种提高产妇和婴幼儿免疫力的雨生红球藻虾青素产品配方 |
CN108902430A (zh) * | 2018-06-25 | 2018-11-30 | 丁红卫 | 一种辅助调理心脑血管疾病组合保健品 |
CN109349553A (zh) * | 2018-11-29 | 2019-02-19 | 徐州市迪港商贸有限公司 | 一种虾青素软胶囊配方 |
CN109481416A (zh) * | 2019-01-02 | 2019-03-19 | 陈丽娟 | 一种虾青素软胶囊 |
CN109770353A (zh) * | 2019-02-01 | 2019-05-21 | 李树森 | 深海鱼油软胶囊及其制备方法 |
CN109907321A (zh) * | 2019-02-15 | 2019-06-21 | 李树森 | 一种高寒地区深海鱼油软胶囊及其制备方法 |
CN113017079A (zh) * | 2019-12-24 | 2021-06-25 | 深圳华大生命科学研究院 | 一种具有延缓机体衰老作用的组合物及其应用 |
RU2778561C1 (ru) * | 2022-01-18 | 2022-08-22 | Общество С Ограниченной Ответственностью "Корякморепродукт Дв" | Способ получения биологически активной добавки |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080299187A1 (en) * | 2007-06-01 | 2008-12-04 | Joar Opheim | Substances for Reducing Occurence of Major Cardiac Events in Humans |
US20110026811A1 (en) * | 2009-07-31 | 2011-02-03 | Hirokazu Kameyama | Image processing apparatus and method, data processing apparatus and method, and program and recording medium |
CN103156198A (zh) * | 2013-04-03 | 2013-06-19 | 上海春芝堂生物制品有限公司 | 一种鱼油软胶囊及其制备方法 |
CN103349289A (zh) * | 2013-06-14 | 2013-10-16 | 芜湖市诺康生物科技有限公司 | 一种鱼油软胶囊的制备方法 |
CN103829234A (zh) * | 2013-12-25 | 2014-06-04 | 无锡市天赐康生物科技有限公司 | 一种提高免疫力降血脂的保健食品及其制备方法 |
-
2014
- 2014-06-29 CN CN201410297613.6A patent/CN104082751A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080299187A1 (en) * | 2007-06-01 | 2008-12-04 | Joar Opheim | Substances for Reducing Occurence of Major Cardiac Events in Humans |
US20110026811A1 (en) * | 2009-07-31 | 2011-02-03 | Hirokazu Kameyama | Image processing apparatus and method, data processing apparatus and method, and program and recording medium |
CN103156198A (zh) * | 2013-04-03 | 2013-06-19 | 上海春芝堂生物制品有限公司 | 一种鱼油软胶囊及其制备方法 |
CN103349289A (zh) * | 2013-06-14 | 2013-10-16 | 芜湖市诺康生物科技有限公司 | 一种鱼油软胶囊的制备方法 |
CN103829234A (zh) * | 2013-12-25 | 2014-06-04 | 无锡市天赐康生物科技有限公司 | 一种提高免疫力降血脂的保健食品及其制备方法 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106942727A (zh) * | 2017-04-20 | 2017-07-14 | 北京市永康年健康科技有限责任公司 | 一种用于降低血脂的dha藻油制品及其制备方法和应用 |
CN106942727B (zh) * | 2017-04-20 | 2018-05-15 | 北京市永康年健康科技有限责任公司 | 一种用于降低血脂的dha藻油制品及其制备方法和应用 |
CN107080769A (zh) * | 2017-05-17 | 2017-08-22 | 王茹 | 一种治疗各种慢性疾病的天然药物及医用配方食品 |
CN107772190A (zh) * | 2017-10-19 | 2018-03-09 | 杭州鑫伟低碳技术研发有限公司 | 一种提高产妇和婴幼儿免疫力的雨生红球藻虾青素产品配方 |
CN108902430A (zh) * | 2018-06-25 | 2018-11-30 | 丁红卫 | 一种辅助调理心脑血管疾病组合保健品 |
CN109349553A (zh) * | 2018-11-29 | 2019-02-19 | 徐州市迪港商贸有限公司 | 一种虾青素软胶囊配方 |
CN109481416A (zh) * | 2019-01-02 | 2019-03-19 | 陈丽娟 | 一种虾青素软胶囊 |
CN109770353A (zh) * | 2019-02-01 | 2019-05-21 | 李树森 | 深海鱼油软胶囊及其制备方法 |
CN109907321A (zh) * | 2019-02-15 | 2019-06-21 | 李树森 | 一种高寒地区深海鱼油软胶囊及其制备方法 |
CN113017079A (zh) * | 2019-12-24 | 2021-06-25 | 深圳华大生命科学研究院 | 一种具有延缓机体衰老作用的组合物及其应用 |
RU2778561C1 (ru) * | 2022-01-18 | 2022-08-22 | Общество С Ограниченной Ответственностью "Корякморепродукт Дв" | Способ получения биологически активной добавки |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104082751A (zh) | 一种含有虾青素的深海鱼油软胶囊 | |
Rizliya et al. | Biological, physical, and chemical properties of fish oil and industrial applications | |
CN107494775A (zh) | 一种食用调和油及其制备方法 | |
CN105238595B (zh) | 一种黄秋葵美容皂及其制备方法 | |
CN104055123A (zh) | 一种含有γ-亚麻酸的深海鱼油软胶囊 | |
CN103989179A (zh) | 含有银杏叶提取物的深海鱼油软胶囊 | |
CN104000208A (zh) | 一种含有角鲨烯的深海鱼油软胶囊 | |
JP6083942B2 (ja) | 長命草及び魚介油を含む組成物 | |
CN101961352A (zh) | 一种无腥味的自乳化的鱼油软胶囊 | |
CN103989181A (zh) | 核桃油鱼油软胶囊 | |
CN107173807A (zh) | 一种含藻类提取物的抗氧化保健营养组合物 | |
KR101380652B1 (ko) | 정제어유를 함유한 장용성 연질캡슐 조성물 및 그의 제조방법 | |
CN103989180B (zh) | 含有丹参提取物的深海鱼油软胶囊 | |
EA028641B1 (ru) | Пищевая липидная композиция, содержащая стеаридоновую кислоту и оливковое масло | |
CN103989176B (zh) | 含有葛根提取物的深海鱼油软胶囊 | |
JP7023732B2 (ja) | 炎症を伴う肝疾患の治療または予防剤 | |
CN103989175A (zh) | 含有罗布麻提取物的深海鱼油软胶囊 | |
CN104082741A (zh) | 一种含有虾青素的海狗油软胶囊 | |
CN103989185A (zh) | 一种含有辅酶q10的深海鱼油软胶囊 | |
JP6892532B2 (ja) | 生体内脂肪酸含量増加剤 | |
CN103989178A (zh) | 含有银杏叶油的深海鱼油软胶囊 | |
CN104432032A (zh) | 一种降血脂的保健食品 | |
CN104920638A (zh) | 一种保健调和油及其制备方法 | |
JP2007022917A (ja) | Pparリガンド活性を有する植物由来の組成物 | |
CN104187727A (zh) | 含有丹参提取物的海狗油软胶囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141008 |